Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0268318 (
ICP
)
10,007
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A quick, simple and effective chromatographic method for the separation of beryllium from a wide range of elements is described. The elements selected comprise elements which can interfere with the determination of beryllium by inductively coupled plasma-atomic emission spectroscopy (ICP-AES) and elements which commonly occur in environmental and industrial sample matrices. Beryllium is separated from all possible
ICP
-AES spectral interfering elements using a single extraction chromatographic (EXC) cartridge containing an acidic chelating organophosphorus extractant, Dipex((R)), sorbed onto an inert polymeric substrate. The separation method has been evaluated using simulated samples generated using several different digestion methods currently employed in beryllium analyses performed in Department of Energy (DOE) facilities. Incorporating a guard cartridge containing either 2-ethyl-1-
hexylphosphonic acid
mono 2-ethyl-1-hexyl ester or bis(2,4,4-trimethylpentyl)phosphinic acid to selectively remove U(VI) allows the isolation of beryllium from samples containing over 100mg of uranium without changing the load, rinse or strip conditions of the method.
...
PMID:A method for the separation of beryllium from spectral interfering elements in inductively coupled plasma-atomic emission spectroscopic analysis. 1897 Feb 53